These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 11870868)
21. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant. Sun T; Bethel CR; Bonomo RA; Knox JR Biochemistry; 2004 Nov; 43(44):14111-7. PubMed ID: 15518561 [TBL] [Abstract][Full Text] [Related]
22. Nanomolar inhibitors of AmpC beta-lactamase. Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668 [TBL] [Abstract][Full Text] [Related]
23. Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases. Caselli E; Powers RA; Blasczcak LC; Wu CY; Prati F; Shoichet BK Chem Biol; 2001 Jan; 8(1):17-31. PubMed ID: 11182316 [TBL] [Abstract][Full Text] [Related]
24. Structure of the wild-type TEM-1 beta-lactamase at 1.55 A and the mutant enzyme Ser70Ala at 2.1 A suggest the mode of noncovalent catalysis for the mutant enzyme. Stec B; Holtz KM; Wojciechowski CL; Kantrowitz ER Acta Crystallogr D Biol Crystallogr; 2005 Aug; 61(Pt 8):1072-9. PubMed ID: 16041072 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of class A and class C beta-lactamases by penems: crystallographic structures of a novel 1,4-thiazepine intermediate. Nukaga M; Abe T; Venkatesan AM; Mansour TS; Bonomo RA; Knox JR Biochemistry; 2003 Nov; 42(45):13152-9. PubMed ID: 14609325 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of beta-lactamases by monocyclic acyl phosph(on)ates. Kaur K; Adediran SA; Lan MJ; Pratt RF Biochemistry; 2003 Feb; 42(6):1529-36. PubMed ID: 12578365 [TBL] [Abstract][Full Text] [Related]
27. Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-beta-lactamases. Johnson JW; Gretes M; Goodfellow VJ; Marrone L; Heynen ML; Strynadka NC; Dmitrienko GI J Am Chem Soc; 2010 Mar; 132(8):2558-60. PubMed ID: 20141132 [TBL] [Abstract][Full Text] [Related]
28. Crystal structure of an acylation transition-state analog of the TEM-1 beta-lactamase. Mechanistic implications for class A beta-lactamases. Maveyraud L; Pratt RF; Samama JP Biochemistry; 1998 Feb; 37(8):2622-8. PubMed ID: 9485412 [TBL] [Abstract][Full Text] [Related]
29. Thermodynamic evaluation of a covalently bonded transition state analogue inhibitor: inhibition of beta-lactamases by phosphonates. Nagarajan R; Pratt RF Biochemistry; 2004 Aug; 43(30):9664-73. PubMed ID: 15274621 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of antibiotic resistance: QM/MM modeling of the acylation reaction of a class A beta-lactamase with benzylpenicillin. Hermann JC; Hensen C; Ridder L; Mulholland AJ; Höltje HD J Am Chem Soc; 2005 Mar; 127(12):4454-65. PubMed ID: 15783228 [TBL] [Abstract][Full Text] [Related]
32. Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum beta-lactamases. Delmas J; Chen Y; Prati F; Robin F; Shoichet BK; Bonnet R J Mol Biol; 2008 Jan; 375(1):192-201. PubMed ID: 17999931 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of direct and cooperative contributions towards the strength of buried hydrogen bonds and salt bridges. Albeck S; Unger R; Schreiber G J Mol Biol; 2000 May; 298(3):503-20. PubMed ID: 10772866 [TBL] [Abstract][Full Text] [Related]
34. Different transition-state structures for the reactions of beta-lactams and analogous beta-sultams with serine beta-lactamases. Tsang WY; Ahmed N; Hinchliffe PS; Wood JM; Harding LP; Laws AP; Page MI J Am Chem Soc; 2005 Dec; 127(49):17556-64. PubMed ID: 16332108 [TBL] [Abstract][Full Text] [Related]
35. IRT and CMT beta-lactamases and inhibitor resistance. Cantón R; Morosini MI; de la Maza OM; de la Pedrosa EG Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():53-62. PubMed ID: 18154528 [TBL] [Abstract][Full Text] [Related]
36. Molecular modeling of Henry-Michaelis and acyl-enzyme complexes between imipenem and Enterobacter cloacae P99 beta-lactamase. Fenollar-Ferrer C; Donoso J; Frau J; Muñoz F Chem Biodivers; 2005 May; 2(5):645-56. PubMed ID: 17192008 [TBL] [Abstract][Full Text] [Related]
37. Three factors that modulate the activity of class D β-lactamases and interfere with the post-translational carboxylation of Lys70. Vercheval L; Bauvois C; di Paolo A; Borel F; Ferrer JL; Sauvage E; Matagne A; Frère JM; Charlier P; Galleni M; Kerff F Biochem J; 2010 Dec; 432(3):495-504. PubMed ID: 21108605 [TBL] [Abstract][Full Text] [Related]
38. Crystal Structure of the Pseudomonas aeruginosa BEL-1 Extended-Spectrum β-Lactamase and Its Complexes with Moxalactam and Imipenem. Pozzi C; De Luca F; Benvenuti M; Poirel L; Nordmann P; Rossolini GM; Mangani S; Docquier JD Antimicrob Agents Chemother; 2016 Dec; 60(12):7189-7199. PubMed ID: 27671060 [TBL] [Abstract][Full Text] [Related]
39. High level QM/MM modeling of the formation of the tetrahedral intermediate in the acylation of wild type and K73A mutant TEM-1 class A beta-lactamase. Hermann JC; Pradon J; Harvey JN; Mulholland AJ J Phys Chem A; 2009 Oct; 113(43):11984-94. PubMed ID: 19791786 [TBL] [Abstract][Full Text] [Related]
40. Investigations on beta-lactamase stability of recently developed beta-lactam compounds: study of enzyme kinetics. Cullmann W; Dick W Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 May; 254(3):413-22. PubMed ID: 6372325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]